Takeda

This is the official Twitter channel of Takeda Pharmaceutical. For more information, read: takeda.info/43ZM9OX

Today the @US_FDA granted priority review of the Biologics License Application for our investigational #dengue vaccine candidate being evaluated for the prevention of dengue virus. Read the release here: bit.ly/3TY6Epl

Every #transformationalmedicine we develop starts with a spark of inspiration; an idea that captures our collective imagination and pushes us to think bigger. Learn more: bit.ly/3tS1ZuI #WhereScienceIs

Are you a healthcare professional working in IBD? Register for the Takeda-organized GUT RESPONSE virtual series: live case discussions, for and by GI specialists! bit.ly/3OqvQ70 #EasternEuropeOnly

After noticing difficulty breathing while running in 2020, Jim was diagnosed with #Alpha1. He was glad he talked to his doctor to get the support and resources he needed. Learn more about Alpha-1 by visiting bit.ly/3sGctwC. #USOnly #Alpha1Awareness

Who will your work make all the difference for? The answer is countless people worldwide. Coming to work here means making a real difference in people’s lives by helping deliver transformative therapies to patients. Learn more: takedajobs.com.
#pharmajobs #hiring

Signing up for job alerts with us is as easy as 1, 2, 3.

Step 1: Go to takedajobs.com
Step 2: Scroll down and fill out the form
Step 3: Click ‘Submit’

...and you’ll receive the latest career opportunities directly to your inbox.

#hiring #careers #pharmajobs

How do you prepare to supply half of the world’s population with a #vaccine for prevention against a potentially life-threatening virus? Learn how we built a 2022 award-winning digital factory to produce our #dengue vaccine in Singen, Germany: bit.ly/3EFsKsk

This #Alpha1Awareness Month, we are committed to increasing awareness of #Alpha1, a rare genetic disorder. Learn more about Alpha-1 by visiting bit.ly/3sGctwC #USOnly

In honor of #VeteransDay last week, we’re highlighting STRIVE, our TRG dedicated to #military-service connected employees. Read more about some events they hosted to celebrate our #veterans: bit.ly/3ApyEeC

Join us at the 2022 @ISID_org Congress as we share the latest findings from our #dengue program, including the 4.5-year safety and efficacy follow-up results from participants in Asia. Learn more about the scientific program here: bit.ly/3tB4j98 #ISIDCongress2022

We work with passion and purpose, motivated by our shared goal to deliver #betterhealth and a #brighterfuture to millions around the world. Learn more: bit.ly/3TCgMUL #WhereScienceIs

We are a proud sponsor of the Alpha-1 Foundation’s Virtual Walk #A1FVW22. Show your support for @AlphaFriend’s mission in finding a cure for Alpha-1 by walking anywhere, anytime, this month! Learn more: bit.ly/3EIr6qw #Alpha1Awareness

Jordan Brayanov & Jesus Gomez-Navarro joined @_DiMeSociety CEO Jennifer Goldsack to share how #pharma can thrive in the #digital era including making digital health tech part of all #clinicaltrials & upskilling the workforce. Read more via @pharmaphorum: bit.ly/3TuaOVU

A #RareDisease like #HereditaryAngioedema can be a burden for patients, but many #HAE patients face even more obstacles due to their age, race, or where they live. Salomé Juethner shares our commitment to meeting the needs of these patients. #ACAAI #ACAAI22

Happy Veterans Day! Today, we are proud to honor all our employees and employees’ family members who have served in the military. Thank you for your service!

#veteransday #military #veteransupport

We are pleased to announce our treatment for post-transplant recipients cytomegalovirus (#CMV) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies received European Commission approval today. Learn more: bit.ly/3UP6DVO

Some post-transplant patients with cytomegalovirus (#CMV) face the challenge of safely swallowing solid tablets. The FDA has expanded the administration of our oral medication to include nasogastric/orogastric tubes. Learn more about transplants: bit.ly/3UGDVa5 #USOnly

We are excited to join the #ACAAI22 Annual Scientific Meeting to share the latest research and updates on how we are continuing to find innovative ways to better serve the #HAE and #PrimaryImmunodeficiency communities. #ACAAI

Developing a vaccine for prevention against a potentially life-threatening virus requires extraordinary innovation. Learn how we built a 2022 award-winning digital factory to produce our #dengue vaccine at our manufacturing site in Singen, Germany: bit.ly/3WM89cV